Navigation Links
Elsevier announces new partnership with CCS to publish the Canadian Journal of Cardiology
Date:11/2/2010

Ottawa, ON, Canada, 2 November, 20 10 Elsevier, a world-leading publisher of scientific, technical, and medical information products and services, is pleased to announce a new partnership with the Canadian Cardiovascular Society and the January 2011 publication of the Canadian Journal of Cardiology, an established journal in the field of cardiovascular medicine.

Under the guidance of Editor-in-Chief Stanley Nattel, MD, FRSC, FRCPC, FACC, FHRS, Paul-David Chair in Cardiovascular Electrophysiology and Professor of Medicine at the University of Montreal and Director of the Electrophysiology Research Program at the Montreal Heart Institute Research Center, and a renowned Editorial Board, this internationally recognized journal publishes peer-review material pertinent to specialists, general practitioners, and cardiovascular scientists and addresses all aspects of cardiovascular medicine.

The Canadian Journal of Cardiology is the official journal of the Canadian Cardiovascular Society. It is a vehicle for the international dissemination of new knowledge in cardiology and cardiovascular science, particularly serving as a major venue for the results of Canadian cardiovascular research and Society guidelines. The Journal publishes original reports of clinical and basic research relevant to cardiovascular medicine as well as editorials, review articles, case reports, and papers on health outcomes, policy research, ethics, medical history, and political issues affecting practice.

"The Canadian Journal of Cardiology has been at the forefront in publishing clinical reports and research relevant to cardiovascular medicine for many years," comments Dr. Nattel, "we are confident that partnering with Elsevier will further our reach and impact in international cardiovascular circles. This is an exciting time for the CJC."

"The Canadian Journal of Cardiology has been and will continue to be the voice of our Society," says CCS President Charles Kerr. The Journal is a key benefit of Society membership. It serves as a vehicle of communication that reinforces the strength of not only the CCS, but the cardiovascular specialty as a whole."

The Canadian Journal of Cardiology will serve as a vehicle to enhance the dissemination of medical knowledge that will benefit people with cardiovascular disease.


'/>"/>

Contact: Jane Grochowski
j.grochowski@elsevier.com
406-542-8397
Elsevier
Source:Eurekalert

Related medicine news :

1. Elsevier/MC Strategies and AORN launch perioperative nursing skills collection
2. Elseviers BrainNavigator 3.0 reflects the next step in enhancing neurological research
3. Elsevier launches new journal: Developmental Cognitive Neuroscience
4. Elsevier introduces SciVerse, an innovative platform for accelerating science
5. Gold Standard/Elsevier first to launch state, federal controlled substance drug schedules
6. Gold Standard/Elsevier promotes medication safety and compliance via New MEDcounselor languages
7. Elsevier partners with Helinet to strengthen consortiums leadership in health sciences education
8. Elsevier partners with ASRT to provide multimedia educational modules through Mosbys Imaging Suite
9. Elsevier and International Society of Geriatric Oncology launch Journal of Geriatric Oncology
10. Elsevier acquires Collexis
11. Elsevier and InfoDesk collaborate to co-develop federated drug pipeline intelligence solution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... Current Meditation , a ... franchising throughout the U.S. starting this spring. Current Meditation focuses on “meditation for ... mainstream. Current Meditation will be the first meditation concept in the U.S. offering ...
(Date:2/23/2017)... ... February 23, 2017 , ... The Center for Autism and ... for Autism Research and Treatment (RI-CART) and Cinemaworld to present Sensory Friendly Films. ... to see films in an environment that accommodates their unique needs. , Launched ...
(Date:2/23/2017)... ... February 23, 2017 , ... CALNOC, the nation’s first and only nursing ... upcoming conference – Empowerment, Value and Collaboration – in Seattle, WA on October 23, ... Virginia Mason Health System in Seattle since 2000. In addition to his role at ...
(Date:2/23/2017)... ... 2017 , ... Curemark, LLC announced today that the Blüm Study, a Phase ... 3-8 with Autism, is now enrolling at three new sites. These new sites are ... , “There are currently no approved drugs that address the core symptoms of ...
(Date:2/23/2017)... Australia (PRWEB) , ... February 23, 2017 , ... ... With perseverance and disciplined exercise regime, the author was able to successfully recover. In ... collates all relevant information for various sources on the principals of massage, anatomy ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , Feb. 23, 2017 MabVax ... oncology drug development company, announces that it has ... Administration (FDA) authorizing the initiation a Phase I ... for pancreatic cancer. MVT-1075 ( 177 Lu-CHX-A?-DTPA-HuMab5B1) is ... MabVax plans to initiate the phase I clinical ...
(Date:2/23/2017)... 23, 2017 Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT) ... oncology and dermatology biopharmaceutical company, today announced that it ... Rodrigues as special advisers to the Company,s Board ... the board on financial and corporate strategy. ... commitment of up to $2.5 million from Eric ...
(Date:2/23/2017)... Feb. 22, 2017 Medical Imaging ... imaging is performed to reveal the internal structures hidden ... the medical condition. It plays a vital role not ... as it is taken into consideration during the follow-up ... X-rays, SPECT/PET, ultrasound, CT, and MRI. For the diagnosis ...
Breaking Medicine Technology: